Vera Therapeutics, Inc.VERANASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+45.5%
5Y CAGR+37.4%
Year-over-Year Change
Research and development spending
3Y CAGR
+45.5%/yr
Annual compound
5Y CAGR
+37.4%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
4.9x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $215.26M | +70.6% |
| 2024 | $126.17M | +61.3% |
| 2023 | $78.22M | +12.0% |
| 2022 | $69.84M | +210.6% |
| 2021 | $22.48M | -48.8% |
| 2020 | $43.92M | +502.4% |
| 2019 | $7.29M | - |